![Piet Wigerinck](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Piet Wigerinck
Direttore/Membro del Consiglio presso IPSEN
Patrimonio netto: 83 446 $ in data 30/06/2024
Posizioni attive di Piet Wigerinck
Società | Posizione | Inizio | Fine |
---|---|---|---|
IPSEN | Direttore/Membro del Consiglio | 01/05/2018 | - |
Independent Dir/Board Member | 01/05/2018 | - | |
University Hospital Antwerp
![]() University Hospital Antwerp Hospital/Nursing ManagementHealth Services University Hospital Antwerp provides clinical, patient care, academic training and scientific research services. The company was is headquartered in Belgium. | Direttore/Membro del Consiglio | - | - |
miDIAGNOSTICS NV
![]() miDIAGNOSTICS NV Miscellaneous Commercial ServicesCommercial Services miDIAGNOSTICS NV develops a computer chip powered portable medical laboratory. The company is headquartered in Leuven, Belgium. | Direttore/Membro del Consiglio | - | - |
Independent Dir/Board Member | - | - | |
Atriva Therapeutics GmbH
![]() Atriva Therapeutics GmbH BiotechnologyHealth Technology Atriva Therapeutics GmbH is a biopharmaceutical company that develops host-targeting antiviral therapies. It focuses on the development of new antiviral therapies against different respiratory viral infections. The company was founded by Rainer Lichtenberger and Henrik Luer Lueßen in April 2015 and is headquartered in Tuebingen, Germany. | Direttore/Membro del Consiglio | - | - |
Independent Dir/Board Member | - | - | |
Symeres BV
![]() Symeres BV Pharmaceuticals: OtherHealth Technology Symeres provides molecule contract research, discovery, development and manufacturing services. The firm offers discovery chemistry, medicinal chemistry, early process research and GMP production services. The company is headquartered in Groningen, the Netherlands. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Piet Wigerinck
Precedenti posizioni note di Piet Wigerinck
Società | Posizione | Inizio | Fine |
---|---|---|---|
GALAPAGOS NV | Direttore Tecnico/Scientifico/R&S | 19/04/2012 | 31/12/2021 |
Corporate Officer/Principal | 01/04/2008 | 19/04/2012 | |
UZA Foundation | Direttore/Membro del Consiglio | - | - |
Xinvento BV
![]() Xinvento BV BiotechnologyHealth Technology Part of Rhythm Pharmaceuticals, Inc., Xinvento BV is a Dutch biotech company that develops therapies for congenital hyperinsulinism. The company is based in Amsterdam, Netherlands. The company was founded in 2021 by Claudine van der Sande, Sarah Hafith-de Boer, Piet Wigerinck. Claudine van der Sande has been the CEO since 2021. Xinvento was acquired by Rhythm Pharmaceuticals Netherlands BV on February 27, 2023 for $222.43 million. | Fondatore | - | - |
Tibotec-Virco Comm Va | Corporate Officer/Principal | - | - |
░░░░ ░░░░░░░░░ ░ ░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Formazione di Piet Wigerinck
Katholieke Universiteit Leuven | Doctorate Degree |
Statistiche
Distribuzione geografica
Belgio | 7 |
Paesi Bassi | 3 |
Francia | 2 |
Posizioni
Director/Board Member | 6 |
Corporate Officer/Principal | 3 |
Independent Dir/Board Member | 3 |
Settori
Health Technology | 6 |
Commercial Services | 3 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
IPSEN | Health Technology |
GALAPAGOS NV | Health Technology |
Aziende private | 8 |
---|---|
University Hospital Antwerp
![]() University Hospital Antwerp Hospital/Nursing ManagementHealth Services University Hospital Antwerp provides clinical, patient care, academic training and scientific research services. The company was is headquartered in Belgium. | Health Services |
miDIAGNOSTICS NV
![]() miDIAGNOSTICS NV Miscellaneous Commercial ServicesCommercial Services miDIAGNOSTICS NV develops a computer chip powered portable medical laboratory. The company is headquartered in Leuven, Belgium. | Commercial Services |
Drug Discovery & Development Solutions Ltd.
![]() Drug Discovery & Development Solutions Ltd. Miscellaneous Commercial ServicesCommercial Services Drug Discovery & Development Solutions Ltd. engages in the provision of financial services. The company is headquartered in Singapore. | Commercial Services |
Atriva Therapeutics GmbH
![]() Atriva Therapeutics GmbH BiotechnologyHealth Technology Atriva Therapeutics GmbH is a biopharmaceutical company that develops host-targeting antiviral therapies. It focuses on the development of new antiviral therapies against different respiratory viral infections. The company was founded by Rainer Lichtenberger and Henrik Luer Lueßen in April 2015 and is headquartered in Tuebingen, Germany. | Health Technology |
Symeres BV
![]() Symeres BV Pharmaceuticals: OtherHealth Technology Symeres provides molecule contract research, discovery, development and manufacturing services. The firm offers discovery chemistry, medicinal chemistry, early process research and GMP production services. The company is headquartered in Groningen, the Netherlands. | Health Technology |
Tibotec-Virco Comm Va | |
Xinvento BV
![]() Xinvento BV BiotechnologyHealth Technology Part of Rhythm Pharmaceuticals, Inc., Xinvento BV is a Dutch biotech company that develops therapies for congenital hyperinsulinism. The company is based in Amsterdam, Netherlands. The company was founded in 2021 by Claudine van der Sande, Sarah Hafith-de Boer, Piet Wigerinck. Claudine van der Sande has been the CEO since 2021. Xinvento was acquired by Rhythm Pharmaceuticals Netherlands BV on February 27, 2023 for $222.43 million. | Health Technology |
UZA Foundation |
- Borsa valori
- Insiders
- Piet Wigerinck
- Esperienza